Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Women news

Show

From To
As strategies to prevent HIV and unintended pregnancies evolve, concepts of “multi-purpose technologies” raise a familiar question . . .

What do women want? While two trials test vaginal rings to fight HIV, market research highlights respondents’ interests in different options.

Published
14 November 2014
From
Science Speaks
"On Demand" PrEP Reduces Risk of HIV Among Gay Men -- But What About Women?

On the heels of news that gay men had very high levels of protection from HIV infection through intermittent pre-exposure prophylaxis (PrEP) timed around sexual activity, a mathematical model predicts that most women would need to stick with a daily dose of Truvada (tenofovir/emtricitabine) to prevent HIV infection from vaginal sex.

Published
12 November 2014
From
The Body Pro
Dissolving Tampons Deliver HIV Drugs (and Maybe Contraception, Too)

University of Washington researchers have created a discreet, quick-dissolving tampon out of silk-line fibers to protect women from HIV. The researchers would ideally like to develop a tampon to protect against HIV, herpes, and pregnancy — an all-in-one shield against the risks of sex. This could prove especially useful in developing countries, where women may not have easy access to other kinds of birth control.

Published
04 November 2014
From
Healthline News
Namibia’s Highest Court Finds Government Forcibly Sterilised HIV-Positive Women

The case was brought by three HIV-positive women who were subjected to sterilisation without their informed consent in public hospitals. The High Court found in favour of the women and held that the practice of coerced sterilisation violated the women’s legal rights.

Published
04 November 2014
From
Southern Africa Litigation Centre (press release)
Injectable rilpivirine shows promise in phase I trials – but may work better for anal than vaginal sex

A phase one dose-finding and safety study in humans of TMC278 LA, a long-acting, injectable formation of the antiretroviral (ARV) drug rilpivirine, found that a single

Published
01 November 2014
By
Gus Cairns
Model Explains Why HIV Prevention Dosing Differs by Sex

A mathematical model developed by NIH grantees predicts that women must take the antiretroviral medication Truvada daily to prevent HIV infection via vaginal sex, whereas just two doses per week can protect men from HIV infection via anal sex. This finding helps explain why two large clinical trials testing HIV pre-exposure prophylaxis, or PrEP, in women failed to show efficacy

Published
31 October 2014
From
National Institute of Allergy and Infectious Diseases (NIAID) press release
Tenofovir gel use associated with lower HSV-2 risk in women

The risk of acquiring herpes simplex virus type 2 (HSV-2) was reduced by 46% (aIRR:0.54, 95%CI:0.30-0.97, p = 0.038) among women who regularly used the vaginal gel containing

Published
30 October 2014
By
Lesley Odendal
How does a ‘human rights based approach’ work out on the ground? Lessons from South Africa

While international rhetoric on HIV and AIDS frequently invokes human rights, putting these ideas into practice in specific settings remains challenging, according to a process evaluation of

Published
29 October 2014
By
Roger Pebody
HIV R4P: Conference co-chair and “vaginal ecologist” Sharon Hillier talks about “the beautiful ecosystem,” and how to make it more resistant to HIV

“People around the world have mysterious notions about the vagina,” Sharon Hillier told a group of journalists and advocates today. Hillier, one of five co-chairs of HIV R4P, the first global conference devoted to biomedical HIV prevention research, is here to explain her work, which she sums up as making vaginas much more resistant to […](Read more...)

Published
28 October 2014
From
Science Speaks
Linking violence against women with HIV and AIDS in Pakistan

Global literature and research shows that the relationship between violence against women and HIV risk is undeniable, complex and involves multiple pathways. Violence against women places women at an increased risk of HIV both through direct risk of infection and through creating an environment in which women are unable to adequately protect themselves from HIV...This involves chronically abusive relationships where women are repeatedly exposed to the same perpetrator.

Published
26 October 2014
From
Daily Ties, Pakistan
← First12345...36Next →

Filter by country